Therapeutic Equivalency
4
Pipeline Programs
2
Companies
4
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
4
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
PfizerNEW YORK, NY
3 programs3
FesoterodinePhase 11 trial
methylprednisolonePhase 11 trial
methylprednisolonePhase 11 trial
Active Trials
BD
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Black Diamond TherapeuticsAzathioprine 50Mg Tab
Pfizermethylprednisolone
Pfizermethylprednisolone
PfizerFesoterodine
Clinical Trials (4)
Total enrollment: 108 patients across 4 trials
Bioequivalence of Azathioprine Suspension 10 mg/mL (Jayempi) Versus Azathioprine Tablet 50mg (Imurek®)
Start: Apr 2019Est. completion: May 2019
Phase 1Completed
A Bioequivalence Study Comparing Methylprednisolone Suspension To Methylprednisolone Tablets
Start: Jan 2012Est. completion: Feb 20120
Phase 1Withdrawn
A Bioequivalence Study Comparing Methylprednisolone Suspension to Methylprednisolone Tablets Under Fed Conditions
Start: Oct 2011Est. completion: Feb 20120
Phase 1Withdrawn
Phase 1, Single Dose, Crossover Study to Determine Bioequivalence and to Investigate Food Effect
Start: Oct 2008Est. completion: Dec 2008108 patients
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space